PHS FOI 2024-001871
- Date of request
- 15 May 2024
- Date of response
- 03 June 2024
- FOI request ID
- PHS FOI 2024-001871
- Drugs
Request
“I am conducting analysis on the treatment of breast cancer and would be grateful if you send me an extract from the Hospital Medicines Utilisation Database (HMUD). I have included a specification on page 2 of this letter. Please send the response as Excel or .csv file.
HMUD fields to include in the data extract:
|
Field |
|
Example (for example only) |
|
Calendar year |
|
2023 |
|
Calendar month |
|
Jan |
|
Name of Health Board |
|
NHS Lothian |
|
Drug substance (INN name of drug) |
|
abemaciclib |
|
Drug product pack name |
Virtual or actual product pack name, whichever are stored in HMUD |
Abemaciclib 100mg tablets or Abemaciclib 150mg tablets or Abemaciclib 50mg tablets |
|
Quantity unit of measure (UOM) |
e.g. tablet, mL, vial, the unit in which the quantity can be measured |
tablet |
|
Quantity issued |
|
numerical value |
Filters
- Time period: start of November 2022 to end April 2024
- Drugs
- Abemaciclib (Verzenios)
- Palbociclib (Ibrance)
- Ribociclib (Kisqali)
- Alpelisib (Piqray)
- Anastrozole (anastrozole or Arimidex)
- Exemestane (exemestane or Aromasin)
- Fulvestrant (fulvestrant or Faslodex)
- Letrozole (letrozole or Femara)”